abstract |
The present invention relates to a combined micronized product comprising a composition selected from the group consisting of ulipristal acetate, ulipristal acetate metabolites and mixtures thereof, and a pharmaceutically acceptable solid surfactant. The invention also relates to a pharmaceutical composition comprising the combined micronized product and its therapeutic use. |